Peptide RegisterUK

Home / Already taking it / Body composition

Muscle, strength and the wasting story

You have been told these drugs strip muscle. The evidence is more favourable than that, and there is still a good reason to lift things.

The short version

The situation

You have read that GLP-1s waste muscle and leave you weak, and you are worried, or somebody is selling you something to prevent it.

The short answer

Evidence reported in June 2026 using genetic methods indicated these drugs reduce fat mass considerably more than lean mass. A large real-world study also found lower fracture risk on semaglutide in type 2 diabetes, which is the opposite of what you would expect if people were being meaningfully weakened.

The catch

Some lean tissue does go with any substantial weight loss, and that is worth managing. The version circulating online, that these drugs specifically waste muscle, overstates it considerably, and it sells a lot of peptides.

This is a reference, not medical advice. Anything about your own treatment is a conversation with whoever prescribes for you.

01What actually happens

Lose a significant amount of weight by any means, and some of what you lose is lean tissue. That is true of surgery, of dieting, and of these drugs. It is not a peculiarity of GLP-1 medicines.

The question is proportion, and the evidence is more reassuring than the discourse. The June 2026 genetic analysis indicated the loss is disproportionately fat. The fracture finding points the same way: if these drugs were leaving people structurally weaker, you would expect more broken bones, and the real-world data reported fewer.

Follow the incentive

The muscle-wasting story is extraordinarily useful to somebody. It is the single most effective way to sell peptides, supplements and training programmes to people who are already anxious about a medication they are taking, and it is repeated most loudly by people with something to sell.

That does not make it false. It does mean the version you encounter is usually the strongest one available rather than the accurate one.

02Why to train anyway

The honest reason is not fear of wasting. It is that clinical reviews on getting the most out of these therapies consistently pair adequate protein with structured resistance training, and lean mass is worth actively keeping regardless of how much you would have lost without trying.

Practical points, and none of these are a programme:

  • Resistance work is the part that matters for keeping muscle. Cardio has its own benefits and is not a substitute for it.
  • Something regular beats something ambitious you stop doing in a fortnight.
  • Eating enough protein is the other half of it, and on these drugs that is the harder half.
  • Strength is worth tracking directly. If what you can lift is steady or rising while weight falls, that tells you more than any scale reading.

If you have not trained before, or you have joint problems, a heart condition or anything else that makes you hesitate, ask your GP practice what is available. Some areas run exercise referral schemes.

03What not to buy

The stack sold for this problem is usually a growth hormone secretagogue, sometimes with IGF-1 LR3, occasionally with a myostatin inhibitor.

  • CJC-1295 and ipamorelin raise growth hormone. No controlled human trial shows that produces muscle, recovery or body composition benefits.
  • IGF-1 LR3 has genuine insulin receptor activity and can cause severe hypoglycaemia. Combined with a drug already affecting your glucose handling, that is a bad pairing.
  • ACE-031 blocks myostatin, and its human trials were stopped early over bleeding and blood vessel problems.

Nobody has studied any of these alongside a GLP-1 medicine, so your prescriber cannot advise you on the combination, and there is no data for them to advise from.

04Questions worth asking

Take these to your GP, practice nurse, pharmacist or specialist team. The answers are specific to you in a way nothing on this page can be.

  1. Is there an exercise referral scheme or physiotherapy input available to me?
  2. Is there any reason I should be careful about resistance training?
  3. Should anything be monitored as my body composition changes?

05Common questions

Do GLP-1 drugs cause muscle loss?

Some lean tissue is lost with any substantial weight loss, by any method. Evidence reported in June 2026 using genetic methods indicated GLP-1 drugs reduce fat mass considerably more than lean mass, and a large real-world study reported lower fracture risk on semaglutide in type 2 diabetes.

Do I need to take something to protect my muscle?

Not an unlicensed compound. The things clinical reviews actually emphasise are adequate protein and resistance training. The peptides sold for this have no human evidence of producing the benefits claimed, and none has been studied alongside a GLP-1 drug.

What kind of exercise is best on a GLP-1?

Resistance training is the part specifically associated with keeping lean mass. Cardio has separate benefits and does not replace it. Consistency matters more than intensity, and your GP practice may be able to point you at a referral scheme.

Should I get a body composition scan?

It can be more informative than a scale, since it separates fat from lean mass. Availability varies and consumer scales are unreliable. Tracking what you can physically lift is free and tells you something real.

06Sources

  1. Genetic evidence on fat versus lean mass2026
  2. Semaglutide and fracture risk, real-world study2026
  3. Optimizing GLP-1 therapies for obesity and diabetes managementPubMed
  4. IGF-1 LR3 recordOn this site
  5. ACE-031 recordOn this site